Literature DB >> 15845672

Dexmedetomidine exerts dose-dependent age-independent antinociception but age-dependent hypnosis in Fischer rats.

Robert D Sanders1, Mariangella Giombini, Daqing Ma, Yoko Ohashi, Mahmuda Hossain, Masahiko Fujinaga, Mervyn Maze.   

Abstract

Dexmedetomidine (Dex), an alpha(2)-adrenoceptor agonist, is an effective analgesic and sedative drug in adults; however, little information is available about its efficacy in pediatric populations. Some anesthetics exhibit an age-dependent analgesic effect, e.g., nitrous oxide, being relatively ineffective in newborn rats. We investigated the analgesic and hypnotic efficacy of Dex using 6 cohorts of Fischer rats aged 7, 15, 19, 23, and 29 days and adults exposed to either Dex (10 or 50 microg/kg) or saline subcutaneously. Formalin plantar testing was used to mimic inflammatory pain, and its effect was assessed using immunohistochemical (c-Fos staining) and behavioral methods. The hypnotic action of Dex was assessed by loss of righting reflex. Formalin administration produced a typical nociceptive response in each age group; these nociceptive responses were significantly attenuated by Dex 50 microg/kg at all ages (P < 0.05), whereas Dex 10 microg/kg had little effect. Neonatal rats showed the greatest hypnotic sensitivity to Dex (P < 0.05).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15845672     DOI: 10.1213/01.ANE.0000149595.41576.B3

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  14 in total

1.  Sedation and analgesia in mechanically ventilated preterm neonates: continue standard of care or experiment?

Authors:  Christopher McPherson
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10

2.  Lateral habenular norepinephrine contributes to states of arousal and anxiety in male rats.

Authors:  Erin M Purvis; Adam K Klein; Aaron Ettenberg
Journal:  Behav Brain Res       Date:  2018-03-09       Impact factor: 3.332

3.  Dexmedetomidine-induced sedation does not mimic the neurobehavioral phenotypes of sleep in Sprague Dawley rat.

Authors:  Abigail G Garrity; Simhadri Botta; Stephanie B Lazar; Erin Swor; Giancarlo Vanini; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep       Date:  2015-01-01       Impact factor: 5.849

4.  Dexmedetomidine versus standard therapy with fentanyl for sedation in mechanically ventilated premature neonates.

Authors:  Keliana O'Mara; Peter Gal; John Wimmer; J Laurence Ransom; Rita Q Carlos; Mary Ann V T Dimaguila; Christie C Davanzo; McCrae Smith
Journal:  J Pediatr Pharmacol Ther       Date:  2012-07

5.  Pre-emptive analgesia and its supraspinal mechanisms: enhanced descending inhibition and decreased descending facilitation by dexmedetomidine.

Authors:  Hao-Jun You; Jing Lei; Ying Xiao; Gang Ye; Zhi-Hong Sun; Lan Yang; Nan Niu
Journal:  J Physiol       Date:  2016-02-04       Impact factor: 5.182

6.  Remifentanil requirements for preventing motor response to skin incision in healthy women anesthetized with combinations of propofol and dexmedetomidine titrated to similar Bispectral Index (BIS) values.

Authors:  X Wu; L-H Hang; Y-F Chen; H Wang; D-H Shao; Z Chen
Journal:  Ir J Med Sci       Date:  2014-08-02       Impact factor: 1.568

7.  Dexmedetomidine and ST-91 analgesia in the formalin model is mediated by alpha2A-adrenoceptors: a mechanism of action distinct from morphine.

Authors:  A Nazarian; C A Christianson; X-Y Hua; T L Yaksh
Journal:  Br J Pharmacol       Date:  2008-09-01       Impact factor: 8.739

8.  Comparison of morphine, oxycodone and the biased MOR agonist SR-17018 for tolerance and efficacy in mouse models of pain.

Authors:  Fani Pantouli; Travis W Grim; Cullen L Schmid; Agnes Acevedo-Canabal; Nicole M Kennedy; Michael D Cameron; Thomas D Bannister; Laura M Bohn
Journal:  Neuropharmacology       Date:  2020-12-17       Impact factor: 5.250

9.  The antinociceptive effect of dexmedetomidine modulates spleen cell immunity in mice.

Authors:  Yeon Jang; Mi-Young Yeom; Eun-Sun Kang; Ji-Won Kang; Ho-Kyung Song
Journal:  Int J Med Sci       Date:  2014-01-11       Impact factor: 3.738

10.  Characterization of spinal alpha-adrenergic modulation of nociceptive transmission and hyperalgesia throughout postnatal development in rats.

Authors:  S M Walker; M Fitzgerald
Journal:  Br J Pharmacol       Date:  2007-05-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.